Phase 1b Double-blind Study to Assess the Safety, Tolerability and Preliminary Efficacy of Resiniferatoxin Versus Placebo for the Treatment of Knee Pain Due to Moderate to Severe Osteoarthritis

Trial Profile

Phase 1b Double-blind Study to Assess the Safety, Tolerability and Preliminary Efficacy of Resiniferatoxin Versus Placebo for the Treatment of Knee Pain Due to Moderate to Severe Osteoarthritis

Recruiting
Phase of Trial: Phase I

Latest Information Update: 26 Jul 2018

At a glance

  • Drugs Resiniferatoxin (Primary)
  • Indications Pain
  • Focus Adverse reactions
  • Sponsors Sorrento Therapeutics
  • Most Recent Events

    • 18 Jul 2018 Status changed from not yet recruiting to recruiting.
    • 31 May 2018 Status changed from planning to not yet recruiting.
    • 04 Apr 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top